COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 – 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3 (“UBC”)
LICENSE AGREEMENT Between: THE UNIVERSITY OF BRITISH COLUMBIA and ABT INNOVATIONS INC. SchedulesLicense Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 123
SHARE PURCHASE OPTION AGREEMENTShare Purchase Option Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
THIS AGREEMENT made as of the 14th day of May, 2021 (the “Effective Date”) between THE UNIVERSITY OF BRITISH COLUMBIA (“UBC”), ABT INNOVATIONS INC. (the “Company”) and ASEP MEDICAL INC. (the “Optionee”).
LICENSE AGREEMENTLicense Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
SEPSET BIOSCIENCES INC., a corporation incorporated under the laws of British Columbia, with a registered and records office at Suite 700 - 401 West Georgia Street, Vancouver, BC Canada V68 5A1
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the U.S. Securities and Exchange Commission, certain portions of this exhibit have been omitted because it is both not material and the type of information that the company treats as...Collaborative Research Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances
Re: Collaborative Research Agreement between The University of British Columbia (“UBC”) and ABT Innovations Inc. (the “Sponsor”) effective as of June 2, 2021 (the “Agreement”); Amendment No. 1
FIRST AMENDMENT TO CONFIDENTIAL DISCLOSURE AGREEMENT DATED 22 SEPTEMBER 2016Confidential Disclosure Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances
This First Amendment (the “Amendment”) to the Confidential Disclosure Agreement, dated 22 September 2016 (the “Agreement”), between ABT Innovations (“COMPANY”) and iFyber LLC (“IFYBER”), is entered into as of 18 May 2021.
EMPLOYMENT AGREEMENT THIS AGREEMENT is made on the 1st day of June 2021. BETWEENEmployment Agreement • August 9th, 2024 • Asep Medical Holdings Inc. • In vitro & in vivo diagnostic substances • British Columbia
WHEREAS the Employer desires to obtain the benefit of the services of the Employee, and the employee desires to render such services on the terms and conditions set forth;
